| 静注CD_3AK细胞治疗晚期肝癌的初步观察 |
| |
| 引用本文： | 傅颖君,刘立生,胡敏.静注CD_3AK细胞治疗晚期肝癌的初步观察[J].江西医学院学报,1997(2). |
| |
| 作者姓名： | 傅颖君 刘立生 胡敏 |
| |
| 作者单位： | 江西医学院新药研究室，南昌铁路卫校生理教研室 |
| |
| 摘 要： | 用培养７ｄ以上的ＣＤ３单抗激活的杀伤细胞（ＣＤ３ＡＫ细胞）加ｒＩＬ－２静注治疗晚期肝癌２１例，其中ＣＲ１例，ＰＲ５例，临床有效率以ＣＲ＋ＰＲ计为２８．９％，明显高于ＬＡＫ细胞抗肝癌疗效。治疗后大多数病人临床症状改善，生活质量提高，外周血ＣＤ３＋、ＣＤ４＋升高，ＣＤ８＋下降，ＣＤ４＋／ＣＤ８＋升高，统计学检验均有显著差异。患者血清ＳＩＬ－２Ｒ水平明显降低（Ｐ＜０．０１）。结果提示：静脉注射ＣＤ３ＡＫ细胞可以降低肝癌患者机体瘤负荷，增强机体免疫力，从而对晚期肝癌产生较好的治疗效果。
|
| 关 键 词： | 单抗激活杀伤细胞／治疗应用 肿瘤／药物疗法 病例报告 |
A Preliminary Observation on Infravenows CD 3AK Cells in the Treatment of Late Hepatoma |
| |
| Fu Yingjun,Liu Lisheng.A Preliminary Observation on Infravenows CD 3AK Cells in the Treatment of Late Hepatoma[J].Acta Academiae Medicinae Jiangxi,1997(2). |
| |
| Authors: | Fu Yingjun Liu Lisheng |
| |
| Abstract: | Twenty one cases of late hepatoma were treated with CD 3 monoclonal antibody activated killer (CD 3AK) cells having been cultured for over seven days blus IL 2 by intravenous injection. Among them one case got complete remission ,five got partial remission and the total effective rate was 28.9% recorded by CR PR,obviously higher than that of LAK cell. After treatment,most patients had clinical symptoms improved,life quality increased,In their peripheral blood the level of CD 3 ,CD 4 increased, CD 8 decreased,CD 4 /CD 8 increased,with significant difference statistically. The level of SIL 2R in patient serum decreased obviously (P<0 01) The results suggest that intravenous in jection CD 3AK cells can reduce the patient's load of tumor,strengthen immunity and thence better therapeutic effect in late hepatoma may be cbtained. |
| |
| Keywords: | CD 3AK cellcomplement words/therapeutic use neoplasms/drug therapy case report |
| 本文献已被 CNKI 等数据库收录！ |
|
